Moderna
MRNA
#957
Rank
$20.68 B
Marketcap
$53.80
Share price
-0.55%
Change (1 day)
-31.59%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -$4.31 Billion USD

According to Moderna 's latest financial reports the company's current earnings are $4.98 Billion USD. In 2023 the company made an earning of -$3.91 Billion USD a decrease over its 2022 earnings that were of $9.60 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$4.31 Billion10.25%
2023 -$3.91 Billion-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 Billion44.7%
2019 -$0.51 Billion28.63%
2018 -$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$35 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.49 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$41.77 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$69.04 M-101.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.89 B-353.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$0.53 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.27 B-571.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.12 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA